GGrantIndex
Sort

11,323 grants matching glioblastoma

Role of FAP-positive cells in immune response to irradiated glioblastoma

$188,198
Claire Isabelle Vanpouille-Box · Weill Medical Coll Of Cornell Univ · R21 · FY2024 · CA

Flourine-18 labeled MDM2 antagonists for PET imaging

$188,169
Satish K. Chitneni · Duke University · R21 · FY2020 · CA

Differential Diagnosis of recurrent GBM versus Radiation Necrosis using MDSCbiomarkers

$188,169
Andrew E Sloan · Case Western Reserve University · R21 · FY2021 · CA

scFvPD1-FLT3 CAR T Cells for the Treatment of Relapsed Acute Myeloid Leukemia

$188,138
Jianhua Yu · Beckman Research Institute/City Of Hope · R21 · FY2020 · CA

Human Endogenous Retroviral Sequences (HERVs) in the development and progression of human glioblastoma

$188,124
Monika Rak · Lsu Health Sciences Center · P20 · FY2021 · GM

MODULATION OF NF-kB ACTIVATION BY A NOVEL MITOCHONDRIAL E3 UBIQUITIN LIGASE

$188,001
Claudio A.p. Joazeiro · Scripps Research Institute, The · R01 · FY2010 · GM

ConProject-001

$187,994
Stuart A Lipton · Scintillon Institute For Photobiology · P30 · FY2016 · NS

De Novo Nucleotide Synthesis as a Mediator of Radiation Resistance and a Therapeutic Target in Glioblastoma

$187,987
Daniel R Wahl · University Of Michigan At Ann Arbor · K08 · FY2023 · CA

Genes and pathways underlying brain overgrowth and focal cortical malformations

$187,962
Ghayda Mirzaa · Seattle Children'S Hospital · K08 · FY2019 · NS

Genes and pathways underlying brain overgrowth and focal cortical malformations

$187,962
Ghayda Mirzaa · Seattle Children'S Hospital · K08 · FY2017 · NS

Clinical and Molecular Studies of Novel Therapeutics in Malignant Brain Tumors

$187,934
Tracy T Batchelor · Massachusetts General Hospital · K24 · FY2008 · CA

De Novo Nucleotide Synthesis as a Mediator of Radiation Resistance and a Therapeutic Target in Glioblastoma

$187,907
Daniel R Wahl · University Of Michigan At Ann Arbor · K08 · FY2022 · CA

5-Lipoxygenase inhibition as an adjuvant glioma therapy

$187,798
Cleveland Clinic Lerner Col/Med-Cwru · R21 · FY2004 · CA

Physical detection of HLA-C binding peptides to identify and predict immunogenic personal neoepitopes for improving cancer vaccines

$187,702
Derin B Keskin · Dana-Farber Cancer Inst · R21 · FY2019 · CA

RSR13 ADMINISTERED TO PATIENTS RECEIVING CRANIAL RADIATION THERAPY

$187,536
University Of Pennsylvania · M01 · FY2000 · RR

RSR13 ADMINISTERED TO PATIENTS RECEIVING CRANIAL RADIATION THERAPY

$187,536
University Of Pennsylvania · M01 · FY2000 · RR

Development of novel compounds to inhibit PRMT5 enzyme in high grade astrocytomas

$187,501
Robert Alan Baiocchi · Ohio State University · R21 · FY2010 · NS

Polymeric Micelles for Targeted Delivery of Contrast Agents Through the Nose-to-Brain Route in Image-Guided Brain Cancer Surgery

$187,500
Hyunah Cho · St. John'S University · R16 · FY2025 · GM

Overcoming apoptotic resistance in glioblastoma by CP-d/n-ATF5, a novel tumor spe

$187,380
Markus D Siegelin · Columbia University Health Sciences · K08 · FY2016 · NS

Overcoming apoptotic resistance in glioblastoma by CP-d/n-ATF5, a novel tumor spe

$187,380
Markus D Siegelin · Columbia University Health Sciences · K08 · FY2014 · NS

Overcoming apoptotic resistance in glioblastoma by CP-d/n-ATF5, a novel tumor spe

$187,380
Markus D Siegelin · Columbia University Health Sciences · K08 · FY2015 · NS

Overcoming apoptotic resistance in glioblastoma by CP-d/n-ATF5, a novel tumor spe

$187,380
Markus D Siegelin · Columbia University Health Sciences · K08 · FY2018 · NS

Electrical spectral imaging using magnetic resonance methods

$187,186
Rosalind J Sadleir · Arizona State University-Tempe Campus · R21 · FY2021 · EB

DECONVOLUTION OF CLONAL HETEROGENEITY FROM BULK AND SINGLE-CELL VARIATION DATA

$187,064
Russell S Schwartz · Carnegie-Mellon University · R21 · FY2017 · CA

Cryo-EM analysis of PI3K signaling complexes in glioblastoma

$186,978
Zhi Sheng · Virginia Polytechnic Inst And St Univ · R21 · FY2021 · CA